Researchers call for investment in cancer control in low- and middle-income countries

November 11, 2015

TORONTO, Nov. 12, 2015--Investments in cancer control--prevention, detection, diagnosis, treatment, and palliative care--are increasingly needed in low- and, particularly, middle-income countries, where most of the world's cancer deaths occur, a paper published today in The Lancet recommends.

Of the 8 million cancer deaths worldwide in 2012, 5 million occurred in middle-income countries and 500,000 in low-income countries, and those numbers are expected to rise substantially mainly due to adult population growth.

Many of these cancer patients received no effective treatment and no opioid drugs to control severe pain, or their families became impoverished paying for treatment.

Researchers led by Dr. Prabhat Jha, director of the Centre for Global Health Research of St. Michael's Hospital and a professor in the Dalla Lana School of Public Health at the University of Toronto, outlined in The Lancet a series of practicable, cost-effective strategies for countries to address most of their preventable or treatable cancer burdens. Most middle-income countries could achieve this coverage within a few years, Dr. Jha said.

The package includes: The paper does not recommend an initial emphasis on cancer screening, which is expensive and requires considerable infrastructure. Screening for breast and prostate cancer have also attracted significant controversy in high-income countries for being only moderately effective or leading to overdiagnosis and overtreatment. The exception is cervical screening, which can be done by visual inspection, can be easily diagnosed and treated inexpensively.

The recommended interventions would cost an additional $20 billion per year for all low- and -middle income countries, Dr. Jha said. Most cancer patients in those countries could not afford to pay for treatment themselves, so governments in low- and middle-income countries would have to expand universal health care spending to 3 per cent of total public spending on health: 2·6 per cent in upper-middle-income countries; 5 per cent in lower-middle-income countries; and 13 per cent in low-income countries (respectively, $5·7, $1·7 and $1·7 annually per capita). In contrast, high-income countries devote three to seven per cent of their total health spending on cancer control.

Rising incomes in middle-income countries could support this expanded spending, but Dr. Jha said low-income countries would need international assistance, starting with three priorities:
  1. Finding ways to lower costs for HPV and other vaccines, cancer drugs, pain medications, screening tests and radiotherapy machines. For example, several international organizations have developed mechanisms to reduce the price of a range of supplies for infectious disease control, using economies of scale, subsidies and other tools.
  2. Connecting low-and middle-income countries to international and regional cancer networks who could share treatment, screening and pain control guidelines.
  3. Support for research.
This study received funding from the Bill and Melinda Gates Foundation, the U.S. National Cancer Institute and the Canadian Institutes of Health Research.

About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in more than 23 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, care of the homeless and global health are among the hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Center, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

Media contact

For more information, or to interview Dr. Jha, please contact:
Leslie Shepherd
Manager, Media Strategy
Phone: 416-864-6094
St. Michael's Hospital
Inspired Care. Inspiring Science.
Follow us on Twitter:

St. Michael's Hospital

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to